This summit aims to establish an in depth state of science on biology, clinical & translational strategies for Gastrointestinal Stromal Tumors, while offering expansive networking between scientists, clinical oncologists, industry, and advocacy groups to foster highest-priority collaborative projects.
Jonathan A. Fletcher, MD
Associate Professor
Harvard Medical School
Brigham and Women´s Hospital
Dana Farber Cancer Institute
Boston, MA, USA
Sebastian Bauer, MD
Professor for Personalized Tumortherapy
Director Sarcoma Center
West German Cancer Center
Dept. of Medical Oncology
University Hospital Essen
Essen, Germany
Julia Ketzer
Project Coordinator
Sarcoma Center
West German Cancer Center
Dept. of Medical Oncology
University Hospital Essen
Essen, Germany
Christina Antonescu - Ping Chi - Ron DeMatteo - Armelle Dufresne - Johanna Falkenhorst - Suzanne George - John Glod - Candace Haddox - Michael C. Heinrich - Adrian Mariño-Enriquez - Thomas Mühlenberg - Toshi Nishida - Wenbin Ou - Lori Rink - Brian Rubin - Piotr Rutkowski - César Serrano - Andrew Wagner
The preliminary GISTT Summit 2024 scientific program and additional information on Break Out Session can be found HERE.
The scientific patronage for the GISTT Summit is taken over by FORTRESS (Forum for Translational Research in Sarcoma) and SASS (Strategic Advances in Sarcoma Science) - two meetings that have been successfully established for Sarcoma and GIST research within the last years.
More information and how to register for either meeting can be found HERE.
The GISTT Summit 2024 will take place at the Oktogon INTERARTES GmbH at Zeche Zollverein, the UNESCO World Heritage Coal Mine Industrial Complex.